160 related articles for article (PubMed ID: 20334456)
1. Hospital resource utilization and costs of inappropriate treatment of candidemia.
Arnold HM; Micek ST; Shorr AF; Zilberberg MD; Labelle AJ; Kothari S; Kollef MH
Pharmacotherapy; 2010 Apr; 30(4):361-8. PubMed ID: 20334456
[TBL] [Abstract][Full Text] [Related]
2. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
3. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study.
Garey KW; Turpin RS; Bearden DT; Pai MP; Suda KJ
Int J Antimicrob Agents; 2007 May; 29(5):557-62. PubMed ID: 17341444
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
5. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock.
Patel GP; Simon D; Scheetz M; Crank CW; Lodise T; Patel N
Am J Ther; 2009; 16(6):508-11. PubMed ID: 19531934
[TBL] [Abstract][Full Text] [Related]
6. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
7. Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?
Leenders NH; Oosterheert JJ; Ekkelenkamp MB; De Lange DW; Hoepelman AI; Peters EJ
Int J Infect Dis; 2011 Jul; 15(7):e453-8. PubMed ID: 21530350
[TBL] [Abstract][Full Text] [Related]
8. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database.
Shorr AF; Gupta V; Sun X; Johannes RS; Spalding J; Tabak YP
Crit Care Med; 2009 Sep; 37(9):2519-26; quiz 2535. PubMed ID: 19623050
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
Davis SL; Vazquez JA; McKinnon PS
Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
11. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
12. Invasive Candida species infection: the importance of adequate empirical antifungal therapy.
Armstrong-James D
J Antimicrob Chemother; 2007 Sep; 60(3):459-60. PubMed ID: 17646200
[TBL] [Abstract][Full Text] [Related]
13. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.
Parkins MD; Sabuda DM; Elsayed S; Laupland KB
J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697
[TBL] [Abstract][Full Text] [Related]
14. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
15. Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines.
Patel M; Kunz DF; Trivedi VM; Jones MG; Moser SA; Baddley JW
Diagn Microbiol Infect Dis; 2005 May; 52(1):29-34. PubMed ID: 15878439
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
17. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
[TBL] [Abstract][Full Text] [Related]
18. Candidaemia in a large teaching hospital: a clinical audit.
Aliyu SH; Enoch DA; Abubakar II; Ali R; Carmichael AJ; Farrington M; Lever AM
QJM; 2006 Oct; 99(10):655-63. PubMed ID: 16935923
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
